Analysis of the pesticide flufenoxuron in apples and kiwifruit by high-performance liquid chromatography.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
The pheromone gland of the moth Epiphyas postvittana was analysed for lipids containing the fatty acyl pheromone analogue (FAPA) of the component, (E)-11-tetradecenyl acetate. The FAPA was found predominantly in the triglycerides (TGs), and to a lesser extent in the choline phosphatides. The FAPA was found to be exclusively on the sn-1 or sn-3 position (probably the latter) of the TGs. When pheromone gland lipid extracts were eluted through silica solid phase extraction, a significant proportion of the FAPA was not recovered. Changes in titre of this non-recoverable FAPA paralleled changes in pheromone titre in females. In contrast, changes in recoverable FAPA (mostly in the TGs) titre showed a gradual increase with time after eclosion. The properties of this non-recoverable FAPA were consistent with it being the CoA ester of the FAPA. Thus, it appears that the FAPA-CoA ester is the immediate lipid precursor of the pheromone, and that the FAPA-containing TGs are formed by reaction of the FAPA-CoA with 1,2-DGs, as a consequence of the rate-limiting reduction of the FAPA-CoA. Finally, injection of PBAN into females decapitated for 3 days resulted in a decrease in recoverable FAPA and an increase in non-recoverable FAPA, suggesting that PBAN influences the lipolysis of TGs. Overall these data suggest that there are two routes for biosynthesis of the pheromone component E11-14:OAc in E. postvittana: a de novo route, directly via the CoA esters of the various fatty acid intermediates, and a less direct route via the lipolysis of FAPA-containing TGs.
Sex pheromone titre in the tortricid moth Epiphyas postvittana follows a pattern commonly observed in other species of moths: an increase to a peak some time after eclosion (2-3days), and then a slow decline as the female ages. Previous work has shown that this decline is not regulated by the pheromone biosynthesis activating neuropeptide PBAN. Using in vivo and in vitro enzyme assays, and fatty acid methyl ester (FAME) analyses of pheromone precursors in the gland, we have investigated this senescent decline in pheromone titre. The enzyme assays have shown that in older females the fatty acid reductase and fatty acid synthesis enzyme systems decrease in activity (relative to younger females), whereas other enzyme systems involved in pheromone biosynthesis, including limited beta-oxidation (2-carbon chain-shortening), (E)-11-desaturation, and acetylation (by an acetyl transferase) remain unchanged in their activity. Of the two enzymatic processes involved, the more important one contributing to the decline appears to be the fatty acid reductase. This is consistent with FAME analyses of pheromone glands in old and young females, which show little difference in levels of saturated FAME, but a significant increase in the level of the putative precursor, (E)-11-tetradecenoate, of the sex pheromone component (E)-11-tetradecenyl acetate. Thus, this decline in fatty acid reductase activity results in a buildup of the precursor as the female ages. The near ubiquity of fatty acid reductases in moth sex pheromone systems suggests that this may be a common mechanism for the senescent decline of sex pheromone titre in moths.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
For the first time, unfolding (6 M guanidine) and refolding of partially proteolysed purified polyphenol oxidase (PPOr) was achieved, with 88% of activity recovered. Optimal refolding conditions consisted in stepwise dialysis of guanidine treated extracts, the dialysis buffers containing 1 M (NH4)2SO4 and 100 microM CuSO4. However, CuSO4 had limited effect on the recovering of PPOr activity, whereas (NH4)2SO4 was essential. Concerning the PPO tertiary structure, denaturing conditions (combinations of boiling and reducing agent) used on SDS-PAGE have shown (i) a compact tertiary structure and (ii) the presence of disulfide bonds in PPOr, accounting for the shift between 27 and 41 kDa, and 41 and 42 kDa, respectively. Resistance to proteolytic cleavage was used to study the conformational changes induced by the denaturing treatments. Folded PPOr was resistant to further proteolysis whereas unfolded PPO was totally digested, indicating the role of tertiary structure of PPOr in the resistance to proteases.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Using a spatial, forced-choice, matching protocol, we have measured observers' ability to equate the contrasts of sinusoidal gratings which vary along differing directions in a 3-dimensional color space. In a given experiment, the observer obtained a perceptual match between the contrasts of two gratings whose chromaticities or luminances varied along differing chromatic directions which were selected from among five axes: an achromatic luminance axis (lum), an isoluminant axis where only S-cone activation varied (S-axis), an isoluminant axis where L- and M-cone activation varied in a complementary manner (LM-axis), an axis where only L-cone activation varied (L-axis), and an axis where only M-cone activation varied (M-axis). Even though these chromatic axes were chosen to activate independent mechanisms involved in the early stages of spatiochromatic visual processing, and despite the distinctly differing appearance of patterns from variations along differing directions, we find that observers can reliably make such pairwise contrast matches. Furthermore there is reasonable consistency of matching contrasts among observers and the pairwise contrast matches exhibit the properties of homogeneity and transitivity. This observed homogeneity and transitivity allows, for each color direction, the specification of a single scaling factor which relates perceptual contrast to physical contrast.
Surface expression of P-selectin is known to be a marker of platelet activation in patients with acute coronary syndromes. However, direct comparisons of flow cytometer data may be obscured by differences in methodology, artifactual platelet activation during washing procedures, choice of antibodies, absence of control measurements, and possible observer bias due to unblinded data collection. We sought to test the hypothesis that the model of flow cytometer represents another variable affecting P-selectin measurements. Platelet P-selectin in whole blood was measured by FACScan (Becton Dickinson, Inc., San Diego, CA, USA) or EPICS XL (Coulter Corporation, Hialeah, FL, USA) flow cytometry in 338 patients presenting with chest pain to the emergency departments of three community hospitals as part of a multicenter diagnostic trial. Platelet expression of P-selectin (% of cell positivity) was consistently higher for each discharge diagnosis when measured with FACScan flow cytometer (13.2+/-4.1 for myocardial infarction, 10.0+/-3.6 for unstable angina, 9.9+/-3.5 for heart failure, 4.7+/-0.1 for gastrointestinal illness, and 6.3+/-0.7 for patients with noncardiac chest pain) when compared with results obtained from the EPICS XL instrument (2.4+/-0.2, 2.5+/-0.2, 2.5+/-0.1, 1.8+/-0.1, and 2.3+/-0.1 respectively, p=0.0001 for all groups). This study reveals marked discrepancies in the level of platelet P-selectin measurement based exclusively on the model of flow cytometer used. If P-selectin is to become a diagnostic tool for differentiating an etiology of chest pain, standardized measurements must be defined for each model of flow cytometer.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.